Hot Features
プレミアム
Lipella Pharmaceuticals Inc (LIPO)
NASDAQ
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic... Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania. 詳細を表示
PITTSBURGH, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious...
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc...
PITTSBURGH, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious...
PITTSBURGH, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York...
Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouthNo FDA-approved therapy currently exists for OLPPatient registry and OLP study...
LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancerNovel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0237 | 6.01217656012 | 0.3942 | 0.4378 | 0.39 | 177959 | 0.41242548 | CS |
| 4 | -0.0172 | -3.95311422661 | 0.4351 | 0.53 | 0.3775 | 823481 | 0.44356784 | CS |
| 12 | -0.06 | -12.5549278092 | 0.4779 | 1.5 | 0.3234 | 3919208 | 0.84478406 | CS |
| 26 | -0.2981 | -41.6340782123 | 0.716 | 1.5 | 0.3234 | 1842115 | 0.84199525 | CS |
| 52 | -0.5421 | -56.46875 | 0.96 | 2.71 | 0.3234 | 1138193 | 1.0522153 | CS |
| 156 | -6.6021 | -94.047008547 | 7.02 | 7.72 | 0.3234 | 771194 | 1.39771784 | CS |
| 260 | -6.6021 | -94.047008547 | 7.02 | 7.72 | 0.3234 | 771194 | 1.39771784 | CS |
glenn1919
3週前
TheFinalCD
3週前
tw0122
3週前
Monksdream
2月前
Monksdream
2月前
TheFinalCD
3月前
Swammmie1040
3月前
Swammmie1040
3月前
PirateLeviathan8
3月前
harry crumb
3月前
MartinLutherKing
3月前
Awl416
3月前
Awl416
3月前
Awl416
3月前
glenn1919
3月前
TheFinalCD
3月前
tw0122
3月前
FALCON1
3月前
oldstocks
7月前
Muhbruh
7月前
Monksdream
7月前
oldstocks
7月前
Monksdream
8月前
crudeoil24
12月前
crudeoil24
12月前
Monksdream
12月前
Awl416
12月前
MiamiGent
2年前
TheFinalCD
2年前
81vette
2年前
81vette
2年前
81vette
2年前
81vette
2年前
81vette
2年前
81vette
2年前
MegaDeath
2年前
makinezmoney
2年前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
